Achieve Life Sciences
ACHV
32 hedge funds and large institutions have $15.2M invested in Achieve Life Sciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
10% more funds holding
Funds holding: 29 → 32 (+3)
2.74% less ownership
Funds ownership: 21.6% → 18.87% (-2.7%)
12% less capital invested
Capital invested by funds: $17.3M → $15.2M (-$2.11M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$302K |
| 2 |
Franklin Resources
San Mateo,
California
|
+$267K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$227K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$199K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$157K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$916K |
| 2 |
Renaissance Technologies
New York
|
-$426K |
| 3 |
Morgan Stanley
New York
|
-$222K |
| 4 |
Two Sigma Investments
New York
|
-$203K |
| 5 |
SC
Shay Capital
New York
|
-$179K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
BlackRock
New York
| $23K | +$18.9K | +2,410 | +737% |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $13K | +$12.2K | +1,552 | New |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $11K | +$7.66K | +976 | +317% |
|
|
GGI
29
Godsey & Gibb Inc
Richmond,
Virginia
| $4K | +$3.55K | +453 | New |
|
|
NFSG
30
Newbridge Financial Services Group
Boca Raton,
Florida
| $3K | – | – | – |
|
31
UBS Group
Zurich,
Switzerland
| $1K | -$3.99K | -509 | -86% |
|
|
32
Millennium Management
New York
| – | -$916K | -101,986 | Closed |
|
33
Walleye Capital
New York
| – | -$245 | -27,307 | Closed |
|
|
PVI
34
Pura Vida Investments
New York
| – | -$153K | -17,000 | Closed |
|
35
Bank of America
Charlotte,
North Carolina
| – | +$361 | +46 | New |
|
ACHV Hedge Fund Activity: Q3 2021 in Review
32 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2021, worth a combined $15.2M — down 12% from $17.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ACHV positions and 4 closed out — a net gain of 4 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $302K. The largest seller was Millennium Management, exiting entirely with an estimated $916K sold.
- 32 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2021, up from 29 in Q2 2021.
- Funds reported $15.2M of Achieve Life Sciences stock for Q3 2021, down 12% quarter-over-quarter.
- 8 funds opened new Achieve Life Sciences positions in Q3 2021 and 4 closed out, a net change of +4 holders.
- The largest Achieve Life Sciences buyer in Q3 2021 was GSA Capital Partners, an estimated $302K added.
- The largest Achieve Life Sciences seller in Q3 2021 was Millennium Management, an estimated $916K sold.
Based on aggregated 13F filings for Q3 2021.